2004
DOI: 10.1634/theoncologist.9-1-80
|View full text |Cite
|
Sign up to set email alerts
|

Complementary and Alternative Therapies for Cancer

Abstract: ABSTRACT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
183
0
11

Year Published

2007
2007
2019
2019

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 294 publications
(205 citation statements)
references
References 100 publications
4
183
0
11
Order By: Relevance
“…Th ey all were very open and interested in the study, asked questions about CAM they used, and a bond and trust were developed between the patient and the physician who was supervising the questionnaire completion. To encourage open communication about CAM use by patients, oncologists should be familiar with the most popular remedies and know where to fi nd reliable information for themselves and for their patients 10 . Th e cost could also be one of the reasons for deciding to use or not to use CAM, since almost half of the patients included in the study had low income (<400 €), and average cost of monthly CAM therapy was 114 €.…”
Section: Discussionmentioning
confidence: 99%
“…Th ey all were very open and interested in the study, asked questions about CAM they used, and a bond and trust were developed between the patient and the physician who was supervising the questionnaire completion. To encourage open communication about CAM use by patients, oncologists should be familiar with the most popular remedies and know where to fi nd reliable information for themselves and for their patients 10 . Th e cost could also be one of the reasons for deciding to use or not to use CAM, since almost half of the patients included in the study had low income (<400 €), and average cost of monthly CAM therapy was 114 €.…”
Section: Discussionmentioning
confidence: 99%
“…9 One of the arenas in which there has been substantial interest in the use of CAM modalities is in the field of oncology, both during active treatment and in the post-treatment survivorship phase. [10][11][12][13][14][15] The majority of published studies have either focused on the treatment phase or have included both patients and survivors without making a distinction between these phases.…”
mentioning
confidence: 99%
“…There is an on-going quest to discover drugs for diseases with genetic defects like cancer [80][81][82][83] . The purpose of investigating the histone code is to uncover the power of the epigenetic code and its use in drug design and discovery.…”
Section: Resultsmentioning
confidence: 99%